Researchers in Colchester have helped uncover a new way to design microscopic medicines that could transform treatment for neurodegenerative diseases. The work has been carried out by an international ...
One of the latest versions of the Parkinson’s glove developed by Española GloveWorks. Photo Courtesy NNMC Steve Cox works with McCurdy Charter School volunteer Gabe Zak. Photo Courtesy NNMC From ...
For many scientists, the global rise in the number of people being diagnosed with the degenerative brain disease has become ...
Parkinson’s disease is a long-term brain condition that affects how people move. It usually develops slowly and is most ...
In a safety review, the FDA identified 14 cases of seizures linked to vitamin B6 deficiency in patients taking carbidopa/levodopa-containing drugs.
The firm intends to launch the trial based on positive results from an open-label Phase I/IIa trial of sasineprocel, previously known as ANPD001.
Drugs containing carbidopa or levodopa should come with information saying they can cause vitamin B6 deficiency and seizures, the regulator said.
Fatigue, cognitive changes and sleep disturbances were as important to patients with early Parkinson’s disease as symptoms ...
Scientists in China have developed a "capsule" delivery system to transplant healthy mitochondria into diseased cells, a breakthrough that could lead to new treatments for Parkinson's disease, rare ...
A boxing class in Baltimore is helping people living with Parkinson's disease make connections in more ways than one.
New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University ...
From standard medications to advanced drug delivery, surgery, and regenerative approaches, Parkinson's treatment options in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results